Exelixis (EXEL) Return on Capital Employed Growth (1y) (2012 - 2026)
Exelixis (EXEL) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 2,400.00 |
| 10 | Exelixis | 14.52 Bn | 13.75 Bn | 590.86 Mn | 933.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 933.00 |
| Jan 2, 2026 | 1,221.00 |
| Oct 3, 2025 | 1,250.00 |
| Jul 4, 2025 | 1,377.00 |
| Apr 4, 2025 | 2,370.00 |
| Jan 3, 2025 | 1,705.00 |
| Sep 27, 2024 | 1,963.00 |
| Jun 28, 2024 | 1,009.00 |
| Mar 29, 2024 | 157.00 |
| Dec 29, 2023 | -82.00 |
| Sep 29, 2023 | -1,518.00 |
| Jun 30, 2023 | -1,147.00 |
| Mar 31, 2023 | -1,372.00 |
| Dec 30, 2022 | -883.00 |
| Sep 30, 2022 | 762.00 |
| Jul 1, 2022 | 1,156.00 |
| Apr 1, 2022 | 1,631.00 |
| Dec 31, 2021 | 1,059.00 |
| Oct 1, 2021 | 40.00 |
| Jul 2, 2021 | -1,234.00 |